{"id":"diabetes-medicines","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Lactic acidosis (metformin-related)"}]},"_chembl":{"chemblId":"CHEMBL1743078","moleculeType":"Antibody"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Diabetes medicines encompass multiple drug classes with different mechanisms of action. Common approaches include stimulating pancreatic beta cells to release more insulin, improving the body's ability to use existing insulin, slowing carbohydrate digestion and absorption, or promoting glucose excretion through the kidneys. The specific mechanism depends on the individual agent within the diabetes medicine category.","oneSentence":"Diabetes medicines work by improving blood glucose control through various mechanisms such as enhancing insulin secretion, increasing insulin sensitivity, or reducing hepatic glucose production.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:44:38.264Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT04040634","phase":"NA","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2019-08-08","conditions":"Diabetes Mellitus, High Blood Pressure, Cardiovascular Diseases","enrollment":9476},{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT06930495","phase":"","title":"The Effect of Adiposity on Muscle and Microvascular Function in HFpEF","status":"ENROLLING_BY_INVITATION","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-12-10","conditions":"Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":95},{"nctId":"NCT07496619","phase":"NA","title":"Effects of Diabetic Educational Intervention and Dietary Supplements on Blood Glucose, Lipid Profile Levels, Body Mass Index, and Pain Management Among Adult Individuals With Painful Diabetic Peripheral Neuropathy.","status":"COMPLETED","sponsor":"Al-Quds University","startDate":"2022-03-01","conditions":"Pain, Glucose Levels, Low-density Lipoprotein Lipid Composition","enrollment":62},{"nctId":"NCT07232381","phase":"","title":"Turkish Validity and Reliability Study of Diabetes-Specific Nutrition Knowledge Questionnaire in Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Yasemin Atik Altinok","startDate":"2023-09-01","conditions":"Type 1 Diabetes","enrollment":150},{"nctId":"NCT06869057","phase":"NA","title":"Re-Engineered Discharge for Diabetes Care Transitions","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Worcester","startDate":"2026-05-01","conditions":"Diabetes Mellitus Type 2, Social Determinants of Health (SDOH), Hospital Readmission","enrollment":412},{"nctId":"NCT02262832","phase":"PHASE3","title":"Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-10-09","conditions":"Lipodystrophy, Diabetes, Hyperlipidemia","enrollment":24},{"nctId":"NCT06217302","phase":"PHASE3","title":"Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease","status":"RECRUITING","sponsor":"Alessandro Doria","startDate":"2024-10-31","conditions":"Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1","enrollment":150},{"nctId":"NCT03527537","phase":"PHASE4","title":"Gestational Diabetes and Pharmacotherapy (GAP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2021-05-04","conditions":"Gestational Diabetes","enrollment":416},{"nctId":"NCT07088068","phase":"PHASE3","title":"A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-08-06","conditions":"Type 1 Diabetes Mellitus","enrollment":723},{"nctId":"NCT06810635","phase":"","title":"Polyphenol Metabotypes in People With Diabetes Type 2","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2026-03-04","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":100},{"nctId":"NCT06632652","phase":"NA","title":"Telenursing System by Providing Health Education and Lifestyle Modification Among Diabetic Patients in Bangladesh","status":"COMPLETED","sponsor":"Hiroshima University","startDate":"2024-10-26","conditions":"Diabetes Mellitus","enrollment":70},{"nctId":"NCT07157475","phase":"","title":"Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors","status":"RECRUITING","sponsor":"Wroclaw Medical University","startDate":"2025-07-01","conditions":"Peripheral Arterial Disease(PAD)","enrollment":300},{"nctId":"NCT07487467","phase":"NA","title":"Autologous SVF Therapy for Type 2 Diabetes","status":"RECRUITING","sponsor":"Kaiser Clinic and Hospital","startDate":"2025-01-20","conditions":"Diabetes Mellitus, Type 2","enrollment":10},{"nctId":"NCT06994468","phase":"NA","title":"Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous Nephropathy","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2025-09-22","conditions":"Membranous Nephropathy","enrollment":48},{"nctId":"NCT03970720","phase":"PHASE2","title":"Restoration of Hypoglycemia Awareness With Metoclopramide","status":"RECRUITING","sponsor":"Simon Fisher","startDate":"2019-05-28","conditions":"Hypoglycemia Unawareness","enrollment":36},{"nctId":"NCT07228195","phase":"PHASE4","title":"SGLT2i Therapy in Islet Transplantation (SIT)","status":"NOT_YET_RECRUITING","sponsor":"University of Minnesota","startDate":"2026-05-15","conditions":"Partial Islet Function, TPIAT, Diabetes","enrollment":40},{"nctId":"NCT05663515","phase":"","title":"A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-09-30","conditions":"Pancreatic Cancer","enrollment":24000},{"nctId":"NCT07482020","phase":"PHASE2","title":"SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2025-03-01","conditions":"Atrial Fibrillation (AF), Hypertension","enrollment":66},{"nctId":"NCT07483151","phase":"","title":"Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","enrollment":110},{"nctId":"NCT03499704","phase":"PHASE4","title":"A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy","status":"COMPLETED","sponsor":"Celltrion Pharm, Inc.","startDate":"2020-02-11","conditions":"Diabetes Mellitus, Type 2","enrollment":133},{"nctId":"NCT06312553","phase":"NA","title":"Remotely Delivered Mindfulness-Based Diabetes Education","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Type 2 Diabetes","enrollment":80},{"nctId":"NCT07481305","phase":"NA","title":"Lifestyle Change Implementation Research Network at PRC at UMass Chan","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Worcester","startDate":"2026-04-15","conditions":"GLP - 1","enrollment":220},{"nctId":"NCT04645693","phase":"","title":"The Impact of Oral Health in HIV Patients on Antiretroviral Therapy","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-02-24","conditions":"HIV, Periodontal Diseases, Caries","enrollment":227},{"nctId":"NCT05013112","phase":"NA","title":"Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2023-01-01","conditions":"Kidney Transplantation, Metabolic Disorder, Metformin","enrollment":105},{"nctId":"NCT06905405","phase":"","title":"The Use of Advanced Imaging in HFpEF","status":"RECRUITING","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2025-08-05","conditions":"Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":40},{"nctId":"NCT07181304","phase":"NA","title":"Peer Support and Remote Patient Monitoring for Black Adults With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Type 2 Diabetes","enrollment":200},{"nctId":"NCT06671587","phase":"PHASE4","title":"iGlarLixi CGM Study in Chinese T2D Individuals After OADs","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-12-10","conditions":"Type 2 Diabetes (T2D)","enrollment":678},{"nctId":"NCT03936829","phase":"NA","title":"Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2019-04-28","conditions":"Lipodystrophy Acquired, Type1diabetes","enrollment":10},{"nctId":"NCT04786262","phase":"PHASE3","title":"A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2021-03-29","conditions":"Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia","enrollment":52},{"nctId":"NCT07351058","phase":"PHASE3","title":"A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2026-03-31","conditions":"Obesity or Overweight, Type 2 Diabetes Mellitus","enrollment":1600},{"nctId":"NCT05580536","phase":"NA","title":"Project Dulce for Arab Americans With Type 2 Diabetes","status":"RECRUITING","sponsor":"Scripps Whittier Diabetes Institute","startDate":"2023-02-17","conditions":"Diabetes Mellitus, Type 2","enrollment":48},{"nctId":"NCT07349199","phase":"","title":"Adherence to Clinical Guidelines on Perioperative Diabetes Care","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital Bispebjerg and Frederiksberg","startDate":"2017-01-01","conditions":"Perioperative Medicine, Diabetes (DM), Diabetes Mellitus","enrollment":22000},{"nctId":"NCT07232537","phase":"","title":"An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea","status":"RECRUITING","sponsor":"Bayer","startDate":"2025-11-20","conditions":"Chronic Kidney Disease, Type 2 Diabetes Mellitus","enrollment":500},{"nctId":"NCT07463859","phase":"NA","title":"Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabetes Mellitus","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2026-04-02","conditions":"Type 2 Diabetes, Halitosis, Periodontitis","enrollment":32},{"nctId":"NCT07195994","phase":"NA","title":"A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes","status":"RECRUITING","sponsor":"QuickSilver Scientific","startDate":"2026-02-05","conditions":"Prediabetes / Type 2 Diabetes","enrollment":90},{"nctId":"NCT07472725","phase":"PHASE2","title":"A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2026-04","conditions":"Diabetes Mellitus, Type 2","enrollment":90},{"nctId":"NCT07351045","phase":"PHASE3","title":"A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight Without Type 2 Diabetes","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2026-03-31","conditions":"Obesity or Overweight","enrollment":2000},{"nctId":"NCT06433414","phase":"NA","title":"PAUSE: Sick Day Medication Management Mobile App Study","status":"NOT_YET_RECRUITING","sponsor":"University of Alberta","startDate":"2026-05-01","conditions":"Chronic Condition, Adverse Event","enrollment":320},{"nctId":"NCT05986136","phase":"PHASE2, PHASE3","title":"Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2023-08-20","conditions":"Inflammatory Bowel Diseases","enrollment":50},{"nctId":"NCT06812988","phase":"PHASE2","title":"Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2025-02-28","conditions":"Type 1 Diabetes Mellitus","enrollment":84},{"nctId":"NCT05781711","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-01-06","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT07471607","phase":"NA","title":"Safety and Effectiveness of Overripe Banana Powder Added to Diabetic Formulas in Type 2 Diabetes","status":"COMPLETED","sponsor":"Universiti Sains Malaysia","startDate":"2025-03-01","conditions":"Type 2 Diabetes, Metabolic Disorders","enrollment":60},{"nctId":"NCT07053319","phase":"PHASE1","title":"SGLT2i, Pioglitazone, and Ketone Production in T2D","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2026-07-20","conditions":"Type 2 Diabetes","enrollment":64},{"nctId":"NCT05282680","phase":"","title":"The Hong Kong Diabetes Biobank","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2014-02-01","conditions":"Diabetes Mellitus, Type 2 Diabetes, Type 1 Diabetes","enrollment":48000},{"nctId":"NCT07145983","phase":"NA","title":"Effect of Peer Support Intervention on Medication Adherence, Self-care and Knowledge Among Patients With Diabetes","status":"COMPLETED","sponsor":"Addis Ababa University","startDate":"2024-12-01","conditions":"Peer Influence, Medication Adherence, Self Care","enrollment":120},{"nctId":"NCT07467967","phase":"NA","title":"Impact of Date Consumption on Metabolic Control and Oxidative Stress in Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"University Tunis El Manar","startDate":"2026-07-15","conditions":"Diabete Type 2","enrollment":130},{"nctId":"NCT07467460","phase":"","title":"Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.","status":"RECRUITING","sponsor":"Neuromed IRCCS","startDate":"2026-02-17","conditions":"PARKINSON DISEASE (Disorder), Alzheimer s Disease, Diabete Type 2","enrollment":500},{"nctId":"NCT07400107","phase":"PHASE3","title":"AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight","status":"NOT_YET_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-05-20","conditions":"Obesity, Overweight, Diabetes Mellitus, Type 2","enrollment":1000},{"nctId":"NCT06384521","phase":"NA","title":"Lifestyle MIND- Feasibility of Wait-list Control","status":"WITHDRAWN","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2025-12","conditions":"Type 2 Diabetes Mellitus, Serious Mental Illness, Schizophrenia","enrollment":""},{"nctId":"NCT07465926","phase":"","title":"Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3","status":"COMPLETED","sponsor":"Chung Shan Medical University","startDate":"2017-01-01","conditions":"Cardiovascular-kidney-metabolic Syndrome, Cardiovascular Disease Risk Factor, Kidney Disease","enrollment":451036},{"nctId":"NCT06717698","phase":"PHASE2","title":"A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2024-12-02","conditions":"Chronic Kidney Disease","enrollment":465},{"nctId":"NCT04596631","phase":"PHASE3","title":"A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-11-02","conditions":"Diabetes Mellitus, Type 2","enrollment":132},{"nctId":"NCT06148376","phase":"","title":"Application of a Protocol of Personalized Medicine in Patients With Type 2 Diabetes Mellitus and Multiple Doses of Insulin in Routine Clinical Care","status":"COMPLETED","sponsor":"Hospital Arnau de Vilanova","startDate":"2023-12-01","conditions":"Type 2 Diabetes Mellitus, Multiple Dose Insulin Therapy","enrollment":239},{"nctId":"NCT03811561","phase":"PHASE3","title":"A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2019-05-08","conditions":"Diabetes Mellitus, Type 2","enrollment":1500},{"nctId":"NCT07415954","phase":"PHASE2","title":"A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-04-17","conditions":"Diabetes Mellitus, Type 2","enrollment":270},{"nctId":"NCT07359105","phase":"NA","title":"Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)","status":"RECRUITING","sponsor":"Sin Gon Kim","startDate":"2026-03-09","conditions":"Dyslipidemia Associated With Type II Diabetes Mellitus","enrollment":2186},{"nctId":"NCT07462104","phase":"","title":"Metabolic Syndrome Associated Diet","status":"NOT_YET_RECRUITING","sponsor":"Recep Tayyip Erdogan University Training and Research Hospital","startDate":"2026-03-23","conditions":"Metabolic Syndrome (MetS), Periodontitis, Diet, Food and Nutrition","enrollment":100},{"nctId":"NCT07432126","phase":"NA","title":"Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal","status":"RECRUITING","sponsor":"Kathmandu University School of Medical Sciences","startDate":"2025-12-14","conditions":"Hypertension (HTN), Diabetes (DM)","enrollment":398},{"nctId":"NCT03984097","phase":"PHASE1","title":"A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Takeda","startDate":"2019-07-29","conditions":"Multiple Myeloma","enrollment":50},{"nctId":"NCT06627309","phase":"","title":"Rapid dFLC Response Predict CHR in AL Amyloidosis","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-10-26","conditions":"Systemic AL Amyloidosis","enrollment":50},{"nctId":"NCT04835493","phase":"NA","title":"Evaluating Telementoring for CHW-centered Diabetes Initiatives","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2022-09-01","conditions":"Diabetes Mellitus, Type 2","enrollment":320},{"nctId":"NCT05965908","phase":"PHASE3","title":"Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-01-30","conditions":"Polycystic Ovary","enrollment":150},{"nctId":"NCT02088658","phase":"NA","title":"Technology Intensified Diabetes Education Study in African Americans","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2013-05","conditions":"Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, Diabetes Mellitus, Non-Insulin-Dependent","enrollment":200},{"nctId":"NCT07258394","phase":"PHASE3","title":"Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-01-27","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT06988306","phase":"NA","title":"Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs","status":"RECRUITING","sponsor":"California Polytechnic State University-San Luis Obispo","startDate":"2026-01-15","conditions":"Diabetes Mellitus, Gestational Diabetes Mellitus (GDM)","enrollment":978},{"nctId":"NCT00756379","phase":"NA","title":"Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2009-03-11","conditions":"Cardiovascular Disease, Atherosclerosis, Coronary Artery Disease","enrollment":1085},{"nctId":"NCT06828549","phase":"NA","title":"MObile Support Adapted to Individual Contexts","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2025-03-21","conditions":"Type 2 Diabetes","enrollment":547},{"nctId":"NCT07452887","phase":"NA","title":"Education and Mobile Reminder Program for Foot Self-Care in Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Selma Sahin","startDate":"2026-02-10","conditions":"Diabetes Mellitus, Diabetic Foot Diabetic Foot Care","enrollment":80},{"nctId":"NCT07448974","phase":"PHASE3","title":"Vitamin D and Type 2 Diabetes - Treat-To-Target","status":"NOT_YET_RECRUITING","sponsor":"Tufts Medical Center","startDate":"2026-05","conditions":"Prediabetes, Type 2 Diabetes (T2DM)","enrollment":100},{"nctId":"NCT06619834","phase":"NA","title":"Financial Navigation and Peer Support to Improve Diabetes Outcomes","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2025-02-11","conditions":"Diabetes Mellitus, Glucose Metabolism Disorders, Metabolic Diseases","enrollment":61},{"nctId":"NCT07448805","phase":"NA","title":"Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit","status":"RECRUITING","sponsor":"University Medical Centre Maribor","startDate":"2026-02-18","conditions":"Diabetes Mellitus, Blood Sugar, Sepsis","enrollment":100},{"nctId":"NCT06200519","phase":"","title":"Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography","status":"ACTIVE_NOT_RECRUITING","sponsor":"University College Cork","startDate":"2024-02-12","conditions":"Diastolic Dysfunction, Neonatal Encephalopathy, Small for Gestational Age at Delivery","enrollment":216},{"nctId":"NCT05378620","phase":"NA","title":"Project Dulce for Filipino-Americans With Type 2 Diabetes","status":"COMPLETED","sponsor":"Scripps Whittier Diabetes Institute","startDate":"2022-10-17","conditions":"Diabetes Type 2","enrollment":29},{"nctId":"NCT07450417","phase":"","title":"Effect of Early Empagliflozin Initiation in Cardiogenic Shock.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2025-03-10","conditions":"Cardiogenic Shock","enrollment":418},{"nctId":"NCT06111508","phase":"NA","title":"The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2023-11-29","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT05754944","phase":"","title":"Study of Peripheral Arterial Disease (PAD) in People With Cancer Who Will Be Having Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-02-22","conditions":"Peripheral Arterial Disease (PAD) in Cancer Patients","enrollment":114},{"nctId":"NCT07063316","phase":"","title":"SGLT2 Inhibitors and Renal Anemia in Japan: RWD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2025-07-23","conditions":"Chronic Kidney Disease","enrollment":15000},{"nctId":"NCT05676970","phase":"NA","title":"Using a Telehealth and Shared Decision-Making Model to Address Preventative Medicine Strategies Among Communities in Louisiana","status":"RECRUITING","sponsor":"Xavier University of Louisiana.","startDate":"2024-01-01","conditions":"Preventative Medicine","enrollment":360},{"nctId":"NCT07447362","phase":"NA","title":"Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study","status":"RECRUITING","sponsor":"Universidad Católica San Antonio de Murcia","startDate":"2024-07-24","conditions":"Cardiovascular Risk Factors, Hypertension, Dyslipidemia","enrollment":220},{"nctId":"NCT07444203","phase":"","title":"Transformative Research in Diabetic Nephropathy 2.0","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-11-12","conditions":"Diabetic Nephropathies, Kidney Diseases, Renal Insufficiency, Chronic","enrollment":200},{"nctId":"NCT07439536","phase":"PHASE4","title":"Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-07-01","conditions":"Liver Cirrhosis With Diabetes","enrollment":64},{"nctId":"NCT07436182","phase":"PHASE4","title":"Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2026-03-01","conditions":"Mitochondria, Metformin","enrollment":176},{"nctId":"NCT07434791","phase":"NA","title":"Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-03","conditions":"Diabetic Kidney Disease (DKD)","enrollment":100},{"nctId":"NCT06488105","phase":"PHASE2","title":"Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-08-05","conditions":"Lipid Disorder, Hypercholesterolemia, Cardiovascular Diseases","enrollment":130},{"nctId":"NCT07441187","phase":"","title":"Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type 2 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-02-20","conditions":"T2DM (Type 2 Diabetes Mellitus)","enrollment":300},{"nctId":"NCT07439562","phase":"NA","title":"Choice-Based Support for Adults Starting or Restarting Antiretroviral Therapy in Cape Town, South Africa","status":"NOT_YET_RECRUITING","sponsor":"University of Cape Town","startDate":"2026-02","conditions":"HIV Care Loss to Followup","enrollment":140},{"nctId":"NCT07436663","phase":"PHASE4","title":"Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-02-01","conditions":"Breast Cancer","enrollment":150},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT07437716","phase":"NA","title":"Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2023-01-01","conditions":"Laparascopic Sleeve Gastrectomy, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus","enrollment":60},{"nctId":"NCT07440706","phase":"NA","title":"Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome","status":"RECRUITING","sponsor":"Kaiser Clinic and Hospital","startDate":"2025-10-15","conditions":"Dumping Syndrome, Post-bariatric Hypoglycemia","enrollment":60},{"nctId":"NCT05985135","phase":"NA","title":"Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-06-01","conditions":"Type 1 Diabetes","enrollment":70},{"nctId":"NCT06605807","phase":"NA","title":"Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-11-13","conditions":"Prescribing Decisions, Diabetes, Multimorbidity","enrollment":150},{"nctId":"NCT03513939","phase":"PHASE1, PHASE2","title":"A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sernova Biotherapeutics Inc.","startDate":"2019-02-07","conditions":"Type 1 Diabetes Mellitus","enrollment":17},{"nctId":"NCT03934021","phase":"","title":"Gut Microbiota in Acute Stroke Patients","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2018-07-01","conditions":"Stroke, Stroke, Acute, Stroke, Ischemic","enrollment":120},{"nctId":"NCT04959487","phase":"NA","title":"Changing Health Through Food Support for Diabetes","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-08-23","conditions":"Type 2 Diabetes, Food Insecurity","enrollment":281},{"nctId":"NCT07428746","phase":"PHASE3","title":"Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-04","conditions":"Diabetes Mellitus, Type 2","enrollment":20},{"nctId":"NCT05912647","phase":"NA","title":"Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-02-03","conditions":"Diabetes, Diabetes Type 2","enrollment":376},{"nctId":"NCT05018585","phase":"PHASE3","title":"A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diamyd Medical AB","startDate":"2022-05-19","conditions":"Type 1 Diabetes Mellitus","enrollment":330},{"nctId":"NCT06890975","phase":"NA","title":"\"F!reF!ghterF!t\": Lifestyle Coaching Interventions for Obese Firefighters (FireFit)","status":"NOT_YET_RECRUITING","sponsor":"Cambridge Health Alliance","startDate":"2026-04-21","conditions":"Obesity and Obesity-related Medical Conditions","enrollment":50}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABDOMINAL DISTENSION"},{"count":1,"reaction":"ABDOMINAL PAIN"},{"count":1,"reaction":"COLD SWEAT"},{"count":1,"reaction":"DIABETES MELLITUS"},{"count":1,"reaction":"DIAPHRAGMATIC INJURY"},{"count":1,"reaction":"DRUG DOSE OMISSION"},{"count":1,"reaction":"DRUG INTOLERANCE"},{"count":1,"reaction":"INJECTION SITE EXTRAVASATION"},{"count":1,"reaction":"INTENTIONAL PRODUCT MISUSE"},{"count":1,"reaction":"PERIPHERAL ISCHAEMIA"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Metformin","Sulfonylureas","Meglitinides","Thiazolidinediones","α-glucosidase inhibitor"],"phase":"marketed","status":"active","brandName":"Diabetes Medicines","genericName":"Diabetes Medicines","companyName":"Mackay Memorial Hospital","companyId":"mackay-memorial-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Diabetes medicines work by improving blood glucose control through various mechanisms such as enhancing insulin secretion, increasing insulin sensitivity, or reducing hepatic glucose production. Used for Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}